- Global Pharma News & Resources

Press Releases

Date Title Company
21-Mar-2019 Penile Implants or Penile Prosthesis Market 2019 : Increasing Technological Advancements in the Medical Industry Wired Release
21-Mar-2019 Sprout Pharmaceuticals Presents Important New Addyi Safety and Tolerability Data through Three Alcohol Interaction Studies in Which There Was No Syncope or Orthostatic Hypotension Requiring Medical Attention and No Increase in Adverse Events of Special Interest Sprout Pharmaceuticals, Inc.
21-Mar-2019 Last Participant out in USA Phase 2 Clinical Trial of BiondVax's M-001 Universal Influenza Vaccine Candidate BiondVax Pharmaceuticals Ltd.
21-Mar-2019 Enzyvant's Investigational Farber Disease Enzyme Replacement Therapy, RVT-801, Receives FDA Fast Track and Rare Pediatric Disease Designations Enzyvant
21-Mar-2019 Paragon Bioservices Appoints New CTSO, Bolsters Leadership Ranks to Support Late-Stage Clinical and Commercial Biopharmaceutical Manufacturing Paragon Bioservices, Inc.
21-Mar-2019 Selvita to Host Conference Call and Webcast on Thursday, March 28 Selvita
21-Mar-2019 Lannett Purchases $24 Million Of Term Loans In Open Market Transactions Lannett Company, Inc.
21-Mar-2019 Adlai Nortye Receives NMPA Approval for Pelareorep (AN1004) in China to Initiate Phase III Clinical Trials Adlai Nortye
21-Mar-2019 Neurovascular Devices/Interventional Neurology Market : Business Demand | Hypothesis Investigation | Segmentation | Forecasts till 2028 Wired Release
21-Mar-2019 Orexo Publishes the Annual Report for 2018 Orexo
21-Mar-2019 BioInvent Unveils Broad Anti-TNFR2 Program to Treat Solid Tumors BioInvent
21-Mar-2019 AB2 Bio Announces Readiness for Recruitment in Pivotal Phase 3 Trial of Tadekinig Alfa, a Novel Human Recombinant Interleukin-18 Binding Protein, in Children with Genetic Diagnosis of NLRC4-MAS Mutation or XIAP Deficiency, with Amended Design in the U.S. B3C newswire
21-Mar-2019 Marinomed Biotech AG (MARI-AT): Solving the insoluble goetzpartners securities Limited
21-Mar-2019 Adrenomed's Adrecizumab successfully passes interim analysis in early septic shock study AdrenOSS-II Adrenomed AG
21-Mar-2019 STADA Arzneimittel AG: Announcement of the Results of the Tender Offer STADA Arzneimittel AG
21-Mar-2019 MagForce AG successfully completes installation of mobile NanoTherm treatment center for brain tumors in Poland MagForce AG
21-Mar-2019 Lead Pharma Announces Start of Phase I Clinical Trials with SAR441169 Candidate Treatment for Psoriasis B3C newswire
21-Mar-2019 The Zur Rose Group accelerates growth Zur Rose Group AG
21-Mar-2019 Probiodrug AG: Probiodrug AG to Publish its Full Year 2018 Results on March 28, 2019 Probiodrug AG
21-Mar-2019 The Zur Rose Group accelerates growth Zur Rose Group AG